Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Serina Therapeutics (SER) Cash from Discontinued Operations (2020 - 2021)

Historic Cash from Discontinued Operations for Serina Therapeutics (SER) over the last 2 years, with Q1 2021 value amounting to -$90000.0.

  • Serina Therapeutics' Cash from Discontinued Operations fell 15113.64% to -$90000.0 in Q1 2021 from the same period last year, while for Dec 2021 it was -$90000.0, marking a year-over-year change of. This contributed to the annual value of -$90000.0 for FY2021, which is 14712.04% down from last year.
  • According to the latest figures from Q1 2021, Serina Therapeutics' Cash from Discontinued Operations is -$90000.0, which was down 15113.64% from -$92000.0 recorded in Q2 2020.
  • Serina Therapeutics' Cash from Discontinued Operations' 5-year high stood at $176000.0 during Q1 2020, with a 5-year trough of -$92000.0 in Q2 2020.